Close Menu

NEW YORK – Cellink announced Monday that it has entered an agreement to acquire Ginolis, a Finnish diagnostic robotics and automation company, for €70 million ($84.8 million).  

Forty percent of the purchase price will be paid in series B shares of Cellink, with the rest paid in cash, Cellink said in a statement. The deal is expected to be completed by March 1. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.